Product Sites

Inspiration. Dedication. Innovation.

Talecris discovers, develops and produces protein therapies for people with life-threatening disorders in a variety of therapeutic areas, including immunology, pulmonary and critical care, coagulation and thrombosis.

Please note: Country-specific regulatory requirements limit the information we can provide about our products. In addition, approved indications (uses), product labels, and packaging for a prescription drug may differ between countries. Please refer to the prescribing information provided for your country of residence.

Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified)

Immune globulin intravenous, sometimes referred to as "IGIV" or "IVIG," is also known as pooled human gamma globulin or, simply, gamma globulin. IGIV belongs to a group of medicines that work by affecting a patient's immune system. For decades IGIV has been used to treat a variety of infectious or inflammatory diseases, as well as for the treatment of a variety of autoimmune disorders. A doctor prescribes IGIV therapy. USA Canada Europe Residents of other countries can learn about Talecris' immunology products on the Talecris International Web site.

Hypermunes™ Hyperimmune Globulin Therapy

Hyperimmune globulin therapy are concentrated immunoglobulins used to treat patients whose immune systems have been compromised. Constant monitoring in steps of the manufacturing and delivery process make these biological products safe, easy, and convenient to use. A doctor or healthcare provider prescribes hyperimmune globulin therapies. USA Residents of other countries can learn about Talecris' immunology products on the Talecris International Web site. Find local distributors by selecting your region on the location map.

Koate®-DVI (Antihemophilic Factor [Human])

Antihemophilic factor is a concentrate containing factor VIII and IX-clotting factors that are used for treatment of persons with hemophilia. Hemophilia is a genetic disorder characterized by the deficiency or absence of one of the proteins (or factors) in blood plasma that is responsible for clotting. Low levels of one of these plasma proteins result in bleeding and difficulty clotting in the affected individual. The most common deficiencies of clotting proteins are factor VIII and factor IX. A doctor or healthcare provider prescribes antihemophilic therapies. USA Residents of other countries can learn about Talecris' coagulation and thrombosis products on the Talecris International Web site. Find local distributors by selecting your region on the location map.

Plasbumin® (Albumin [Human]) and Plasmanate®, (Plasma Protein Fraction [Human])

Human albumin is a protein manufactured by the liver. It performs multiple functions, including the transport of many small molecules in the blood. Albumin products are used to manage serious and often life-threatening conditions, such as shock and blood loss due to trauma, burns, and surgery. A doctor or healthcare provider prescribes albumin. USA Canada Residents of other countries can learn about Talecris' pulmonary and critical care products on the Talecris International Web site. Find local distributors by selecting your region on the location map.

Prolastin® (Alpha1- Proteinase Inhibitor [Human])

Alpha1-antitrypsin deficiency, also known as Alpha-1, is an inherited disorder that causes significant reduction in the naturally occurring protein alpha1 antitrypsin (AAT). Scientists also call this protein alpha-1 proteinase inhibitor (A1 PI) because it inhibits not only trypsin but also other enzymes called proteinases. A doctor or healthcare provider prescribes an alpha-1 proteinase inhibitor. USA Canada Europe Residents of other countries can learn about Talecris' pulmonary and critical care products on the Talecris International Web site. Find local distributors by selecting your region on the location map.

Thrombate III® Antithrombin III (Human)

Antithrombin III (AT-III) is a blood protein that inhibits or stops the clotting factors in blood. Approximately 75% of the body's plasma coagulation inhibitory activity is derived from AT-III. AT-III deficiency is a rare inherited or spontaneously occurring condition that affects 1 in every 2,000 to 5,000 males and females worldwide. Individuals with the condition lack the AT-III protein and spontaneous clotting can occur as a result of normal, daily activity. A doctor or healthcare provider prescribes Antithrombin III. USA Residents of other countries can learn about Talecris' coagulation and thrombosis products on the Talecris International Web site. Find local distributors by selecting your region on the location map.